Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response
Cancers · 18.01.2023 · 15 (3) · 597
DOI: 10.3390/cancers15030597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 18.01.2023. Verfasst von Marylène Lejeune und 22 weiteren Autor:innen. Beteiligte Einrichtung: Oncological Pathology and Bioinformatics Research Group, Molecular Biology and Research Section, Pathology Department, Hospital de Tortosa Verge de l…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, “PATH-IMAGE” project.
Themen: Onkologische Pflege
Abstract (Originalsprache)
With a high risk of relapse and death, and a poor or absent response to therapeutics, the triple-negative breast cancer (TNBC) subtype is particularly challenging, especially in patients who cannot achieve a pathological complete response (pCR) after neoadjuvant chemotherapy (NAC). Although the tumor microenvironment (TME) is known to influence disease progression and the effectiveness of therapeutics, its predictive and prognostic potential remains uncertain. This work aimed to define the residual TME profile after NAC of a retrospective cohort with 96 TNBC patients by immunohistochemical staining (cell markers) and chromogenic in situ hybridization (genetic markers). Kaplan–Meier curves were used to estimate the influence of the selected TME markers on five-year overall survival (OS) and relapse-free survival (RFS) probabilities. The risks of each variable being associated with relapse and death were determined through univariate and multivariate Cox analyses. We describe a unique tumor-infiltrating immune profile with high levels of lymphocytes (CD4, FOXP3) and dendritic cells (CD21, CD1a and CD83) that are valuable prognostic factors in post-NAC TNBC patients. Our study also demonstrates the value of considering not only cellular but also genetic TME markers such as MUC-1 and CXCL13 in routine clinical diagnosis to refine prognosis modelling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncological Pathology and Bioinformatics Research Group, Molecular Biology and Research Section, Pathology Department, Hospital de Tortosa Verge de la Cinta, IISPV, URV, 43500 Tortosa, Spain.
- Clinical Studies Unit, Hospital de Tortosa Verge de la Cinta, Carretera Esplanetes, 14, 43500 Tortosa, Spain.
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Gran Via Corts Catalanes, 587, 08007 Barcelona, Spain.
- Pathology Department, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.
- Pathology Department, Hospital Universitari de Vall Hebron, 08035 Barcelona, Spain.
- Pathology Department, Hospital Universitari Sant Joan de Reus, 43204 Reus, Spain.
ORCID-Profile: Marylène Lejeune, Laia Reverté, Noèlia Gallardo, Ramon Bosch, Luis de la Cruz-Merino, Meritxell Arenas, Anna Korzynska
Förderung
- Instituto de Salud Carlos III
- “PATH-IMAGE” project
Zitieren
APA
Lejeune, M., Reverté, L., Sauras, E., Gallardo, N., Bosch, R., Roso, A., Petit, A., Peg, V., Riu, F., García-Fontgivell, J., Ibáñez, J., Relea, F., Vieites, B., Bor, C., de la Cruz-Merino, L., Arenas, M., Rodriguez, V., Galera, J., Korzynska, A., …, & López, C. (2023). Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response. Cancers, 15(3), 597. https://doi.org/10.3390/cancers15030597
Vancouver
Lejeune M, Reverté L, Sauras E, Gallardo N, Bosch R, Roso A, et al. Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response. Cancers. 2023;15(3):597. doi:10.3390/cancers15030597
BibTeX
@article{Lejeune2023,
author = {Lejeune, Marylène and Reverté, Laia and Sauras, Esther and Gallardo, Noèlia and Bosch, Ramon and Roso, Albert and Petit, Anna and Peg, Vicente and Riu, Francisco and García-Fontgivell, Joan and Ibáñez, José and Relea, Fernanda and Vieites, Begoña and Bor, Catherine and de la Cruz-Merino, Luis and Arenas, Meritxell and Rodriguez, Valerie and Galera, Juana and Korzynska, Anna and Belhomme, Philippe and Plancoulaine, Benoît and Álvaro, Tomás and López, Carlos},
title = {Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {597},
doi = {10.3390/cancers15030597}
}
EUVIMED